Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rank in Stocks #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Share Price
$0.00023723
Last synced: 2024-08-26
Market Cap
$1.41K
Change (1 day)
111.67%
Change (1 year)
0.00%
Country
FR
Trade Pharnext S.A. (ALPHA)

Category

Number of shares outstanding for Pharnext S.A. (ALPHA)
Number of shares outstanding as of December 2023: 736.02K
According to Pharnext S.A. latest financial reports and stock price the company's current number of shares outstanding is 736.02K. At the end of December 2022 the company had 736.02K shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Pharnext S.A. (ALPHA) from 2013 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 736.02K 0.00%
2023 736.02K 0.00%
2022 736.02K 0.00%
2021 736.02K 0.00%
2020 736.02K 0.00%
2019 736.02K 0.00%
2018 736.02K 0.00%
2017 736.02K 0.00%
2016 736.02K 0.00%
2015 736.02K 0.00%
2014 736.02K 0.00%
2013 736.02K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M 34,396.16%
US
62.19M 8,348.83%
NL
- -
CH
- -
KR
0.00 -100.00%
BE